GlassScriptPhysician profile
Athol W Morgan
NPI 1366453615
$19,870.47
in general payments reported to CMS, 2019-2025
43 companies · $10K in 2025
The $10K reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,076 · 2020: $584 · 2021: $833 · 2022: $1,076 · 2023: $2,167 · 2024: $2,074 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,135 · Consulting Fee: $5,810 · Travel and Lodging: $1,324 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,134.80 |
| Consulting Fee | $5,810.00 |
| Travel and Lodging | $1,324.26 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $7,525.39 | 2021-2025 | Biktarvy |
| Medtronic Vascular, INC. | $2,179.67 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,199.81 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $1,033.55 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $969.51 | 2019-2025 | |
| Novo Nordisk INC | $742.83 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Pfizer INC. | $648.18 | 2019-2025 | |
| Alnylam Pharmaceuticals INC. | $550.31 | 2022-2025 | Amvuttra, Onpattro |
| Kestra Medical Technology Services, INC. | $511.64 | 2025 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $487.81 | 2021-2025 | |
| Boston Scientific Corporation | $403.50 | 2019-2025 | Bodyguardian, Synergy, Emblem Mri S-Icd |
| Scpharmaceuticals INC. | $393.81 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $376.61 | 2023-2025 | Jardiance |
| Philips North America LLC | $223.67 | 2020-2025 | Ambulatory Monitoring & Diagnostics Undivided, (Cm9) Amb Mon & Diag Und, (Ck4) Mcot |
| Irhythm Technologies, INC. | $217.68 | 2024 | Zio Xt Patch, Zio Monitor |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $207.79 | 2021-2025 | Farxiga, Airsupra |
| Lexicon Pharmaceuticals, INC. | $187.61 | 2023 | Inpefa |
| Merck Sharp & Dohme LLC | $186.70 | 2021-2025 | Verquvo |
| Stryker Corporation | $177.35 | 2025 | Flowtriever |
| Medtronic, INC. | $176.85 | 2022-2025 | Micra, Linq II, Reveal Linq |
| Esperion Therapeutics, INC. | $157.39 | 2021-2023 | Nexletol |
| Neurocrine Biosciences, INC. | $121.84 | 2020-2024 | Ingrezza |
| Actelion Pharmaceuticals US, INC. | $119.84 | 2023 | Opsumit, Uptravi |
| E.R. Squibb & Sons, L.L.C. | $115.17 | 2019-2025 | Camzyos |
| Idorsia Pharmaceuticals US INC | $114.47 | 2023 | Quviviq |
| Kiniksa Pharmaceuticals International, Plc | $89.73 | 2024 | Arcalyst |
| Biotronik INC. | $89.55 | 2019-2021 | |
| Getinge USA Sales, LLC | $74.40 | 2025 | Vasoview Hemopro 2 |
| Exact Sciences Corporation | $65.83 | 2023-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $64.76 | 2019-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Inari Medical, INC. | $63.90 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Kiniksa Pharmaceuticals, LTD. | $62.96 | 2022-2023 | Arcalyst |
| Dynavax Technologies Corporation | $61.26 | 2021-2022 | |
| Dexcom, INC. | $54.21 | 2021 | |
| Amgen INC. | $40.47 | 2022 | |
| Atricure, INC. | $32.34 | 2023 | |
| Lilly USA, LLC | $24.79 | 2025 | Mounjaro, Zepbound |
| Inspire Medical Systems, INC. | $24.61 | 2024 | Inspire |
| Cardiva Medical, INC. | $22.92 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Abiomed | $20.21 | 2024 | Impella |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.51 | 2024 | Xifaxan |
| Glaxosmithkline, LLC. | $17.43 | 2025 | Shingrix, Arexvy |
| Sanofi-Aventis U.S. LLC | $13.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Athol Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.